← Conference Speakers

Floris Wolswijk

Founder, Blossom

Speaking at ICPR 2026 (Interdisciplinary Conference on Psychedelic Research)

Whether European health systems can afford psychedelic therapy once approved

Founded Blossom, a data platform tracking clinical trials, published research, and regulatory developments across the psychedelic field, and writes for Lucid News. At ICPR 2026, spoke on a panel about psychedelic therapy reimbursement — the gap between regulatory approval and whether health systems will actually pay for it.